Brainstorm cell therapeutics inc. (BCLI)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-18,486

-

-

-

-7,516

-5,465

-4,952

-5,852

-5,055

-4,977

-4,982

-5,742

-6,739

-8,042

-8,488

-9,834

-9,652

-9,371

-9,246

-7,733

-6,394

-5,928

-4,899

-4,260

-4,328

-3,640

-3,430

-7,878

-7,422

-4,085

-3,918

0

0

0

Less - loss for the period from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

169

164

135

131

129

110

117

107

94

85

79

73

77

77

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

99

103

104

106

100

97

89

97

117

130

152

157

154

154

153

153

0

0

0

Severance pay, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

Severance pay, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-14

-23

0

0

0

Accrued interest on loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3

3

3

0

0

0

Amortization of discount on short-term loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Change in fair value of options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

Shares and options granted to service providers

0

25

127

127

127

102

0

0

0

-

0

-

-

121

121

31

139

108

120

196

88

198

200

135

209

227

0

0

0

-

-

-

-

-

-

-

-

Change in fair value of options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Expenses related to shares and options granted to service providers

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

249

235

473

449

0

0

0

Deferred Stock-based compensation related to options granted to employees and directors

842

764

901

919

1,002

917

754

734

655

554

397

353

558

635

516

632

691

835

1,401

1,394

1,249

1,024

813

458

593

674

559

761

586

560

783

0

0

-

0

-

-

Finance lease expense (income)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other accounts expenses and other current assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in lease liability

-

-

0

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in other accounts receivable and prepaid expenses

-

-

265

-115

-

238

1,877

1,986

2,984

2,792

212

-367

-186

-379

-726

966

-164

-204

-460

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation related to options granted to employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Decrease (increase) in accounts receivable and prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

124

166

155

74

216

49

426

95

323

409

-105

0

0

0

Increase (decrease) in trade payables

-458

10,129

6,542

4,583

1,768

3,124

2,327

3,955

2,899

1,079

-77

-128

81

-824

17

-400

-641

-373

-969

-2

596

1,314

858

384

80

-130

252

-142

-79

114

35

219

-76

-63

0

0

0

Increase in deferred grant income

0

-

-130

-1,885

-691

-2,625

-5,120

1,885

1,202

2,625

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in other accounts payable and accrued expenses

-467

50

1,755

-302

1,824

170

444

1,596

689

975

-228

-443

-534

-1,264

-1,660

-844

-843

212

1,412

746

523

467

105

174

451

306

-92

-96

-147

-105

417

-21

-244

-64

0

0

0

Revaluation of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

26

-12

679

1,743

1,550

1,588

897

-174

0

0

0

-

-

-

-

-

-

-

-

Erosion of restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,953

-8,208

-8,452

-7,408

-7,236

-5,676

0

-

0

0

-

-

-

-

-2,859

-2,935

-2,710

-2,533

-2,914

-2,223

0

0

0

Net cash used in discontinued operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash used in operating activities

-25,441

-11,247

-11,692

-14,660

-11,097

-12,388

-11,600

-1,163

-2,848

-2,364

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-3,775

-4,054

-3,142

-3,503

-2,859

-2,935

-2,710

-2,533

-2,914

-2,223

0

0

0

Cash flows from investing activities:
Purchase of property and equipment

476

473

235

134

328

369

323

408

225

180

125

50

77

103

145

146

71

45

63

51

67

161

105

136

182

108

112

95

58

90

85

72

63

48

0

0

0

Changes in short-term deposit

-967

-6,089

-10,160

-13,602

628

849

2,111

14,244

-5,384

-4,170

-2,155

-9,604

-2,990

-6,084

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Changes in short-term deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,841

18,394

17,855

4,290

-3,186

-1,780

-1,772

-2,769

0

0

0

-

-

-

-

-

-

-

-

Changes in short-term deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Investment in lease deposit

-

-

-4

-5

-

-

7

10

8

4

1

1

3

4

3

3

3

1

2

6

8

-1

-7

-11

-10

5

11

9

6

0

-8

-8

-17

-16

0

0

0

Proceeds from issuances of common stock through equity warrants and options exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuances of common stock through equity warrants and options exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of Common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

3,576

3,571

5,273

5,273

5,023

5,028

-24

-5

3,602

0

0

0

Net cash used in discontinued investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by (used in) investing activities

491

5,616

9,929

13,473

-951

-1,218

-2,441

-14,662

5,151

3,986

0

0

0

-

-

-

-

-

-

-

-

-

-

-

1,600

2,656

-4,890

-1,865

-1,817

-2,840

-93

-80

-80

-64

0

0

0

Cash flows from financing activities:
Total net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,087

7,740

7,048

-11,283

-13,787

-15,728

0

-

0

0

-

-

-

-

-1,817

-2,840

-93

-80

-80

-64

0

0

0

Proceeds from exercise of options

64

35

35

5

0

25

234

309

339

314

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares in at-the-market (ATM) offering (Note 7)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares and warrants in Registered Direct Offering (Note 7)

13,083

3,126

3,172

12,040

0

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from loans, notes and issuance of warrants, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

Proceeds from equity offering through issuances of equity warrants and common stock through the exercise of previously issued equity warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,409

12,409

12,409

12,397

0

1

1

8

8

7

7

126

146

168

581

480

515

0

0

0

Redemption of warrants in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

600

600

600

0

-

0

0

-

-

-

-

-

-

-

-

-

Repayment of short-term loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

111

111

123

14,868

15,123

24,396

0

-

0

0

-

-

-

-

5,399

5,169

5,196

557

475

4,117

0

0

0

Net cash provided by discontinued financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Total net cash provided by financing activities

34,183

5,225

3,161

51

12,040

12,065

12,274

12,303

339

314

0

0

0

-

-

-

-

-

-

-

-

-

-

-

3,334

3,584

3,578

5,280

5,399

5,169

5,196

557

475

4,117

0

0

0

Increase in cash and cash equivalents

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in cash and cash equivalents

-

-

-

-

-

-

-

-

2,642

1,936

1,509

4,840

-1,609

119

245

-357

-1,281

-3,823

-8,259

-10,027

467

748

8,640

10,573

1,159

2,186

-4,454

-88

723

-606

2,393

-2,056

-2,519

1,830

0

0

0

Stock issued for warrants exchange

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

Exercise of liability classified warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

130

46

46

88

-42

42

42

0

-

0

0

-

-

-

-

-

-

-

-

-

Total non-cash financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

Conversion of convertible loan and convertible note to shares Conversion of trade payable to Common Stock $ 84

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

140

0

0

0

Conversion of other accounts payable to Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Conversion of a trade payable to Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0